The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence*
Abstract
Nicotine is the primary addictive compound in tobacco smoke. In this review we summarize nicotine dependence and the genetics of smoking in brief before focusing on cytochrome P450 (CYP) 2A6. In humans nicotine is mainly inactivated to cotinine and CYP2A6 mediates approximately 90% of this conversion. Some, but not all, studies suggest that genetic variation in CYP2A6 may play a role in smoking. We review some of the recent findings on the influence of CYP2A6 genetic polymorphisms on nicotine kinetics, smoking behaviors, and how the gene appears to exert differential effects during various stages of smoking (eg, initiation, conversion to dependence, amount smoked during dependence, and quitting). These new findings will be put in the context of the discrepancies found in the literature. Implications of these recent findings on current and novel treatment approaches for smoking cessation and tobacco-related lung cancer will also be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Estimates of global mortality attributable to smoking in 2000
Ezzati, M., & Lopez, A. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14338-3 · Cited by 1,247
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141 · cited 1×
“A common voked auditory deficit (P50) among schizophrenic paients,(27) which can be normalized by nicotine,(28) has een linked to the 7 nicotinic receptor subunit gene nd may be one explanation for the association of this ene variant and a high smoking prevalence in this roup.(29) Together, these studies provide convi…”
BackgroundEffects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073
Nicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
The scientific case that nicotine is addictive
Stolerman, I. P., & Jarvis, M. J. (1995) · Psychopharmacology · doi:10.1007/bf02245088 · Cited by 649
Reward deficiency syndrome: genetic aspects of behavioral disorders
Comings, D. E., & Blum, K. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26022-6 · Cited by 621
Predictors of smoking cessation in a cohort of adult smokers followed for five years
Hymowitz, N., Cummings, K., Hyland, A., Lynn, W., Pechacek, T., & Hartwell, T. (1997) · Tobacco Control · doi:10.1136/tc.6.suppl_2.s57 · Cited by 593
Pharmacology of Nicotine: Addiction and Therapeutics
Benowitz, N. L. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.003121 · Cited by 589 · cited 1×
“Nicotine inhaled from cigarette smoke enters the ungs, is rapidly absorbed by the pulmonary capillaries, nd reaches the brain within 10 to 19 seconds after nhalation.(15) Nicotine has a distribution half-life of 15 o 20 minutes and an elimination half-life of 1 to 2 ours.”
BackgroundInitial symptoms of nicotine dependence in adolescents
DiFranza, J. R. (2000) · Tobacco Control · doi:10.1136/tc.9.3.313 · Cited by 574
Stages in the development of adolescent smoking
Mayhew, K. P., Flay, B. R., & Mott, J. A. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00165-9 · Cited by 534
Metabolism of nicotine to cotinine studied by a dual stable isotope method
Benowitz, N. L., & Jacob, P. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.169 · Cited by 508
Nicotine-Induced Limbic Cortical Activation in the Human Brain: A Functional MRI Study
Stein, E. A., Pankiewicz, J., Harsch, H. H., Cho, J.-K., Fuller, S. A., Hoffmann, R. G., Hawkins, M., Rao, S. M., Bandettini, P. A., & Bloom, A. S. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.8.1009 · Cited by 484
The genetic epidemiology of smoking
Sullivan, P., & Kendler, K. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011811 · Cited by 458
A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes
Messina, E. S., Tyndale, R. F., & Sellers, E. M. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36947-2 · Cited by 453
Self-citationNicotine metabolism defect reduces smoking
Pianezza, M. L., Sellers, E. M., & Tyndale, R. F. (1998) · Nature · doi:10.1038/31623 · Cited by 432
Self-citationNicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity*1
DEMPSEY, D. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.02.011 · Cited by 429
Role of human cytochrome P4502A6 in C-oxidation of nicotine.
Nakajima, M., Yamamoto, T., Nunoya, K., Yokoi, T., Nagashima, K., Inoue, K., Funae, Y., Shimada, N., Kamataki, T., & Kuroiwa, Y. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08453-3 · Cited by 418
Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics
Adler, L. E., Hoffer, L. J., Griffith, J., Waldo, M. C., & Freedman, R. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90073-9 · Cited by 412
Yamazaki, H., Inui, Y., Yun, C.-H., Guengerich, F. P., & Shimada, T. (1992) · Carcinogenesis · doi:10.1093/carcin/13.10.1789 · Cited by 398
Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies
Perry, D. C., Dávila-Garcı́a, M. I., Stockmeier, C. A., & Kellar, K. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38304-1 · Cited by 362
Motivational Influences on Cigarette Smoking
Baker, T. B., Brandon, T. H., & Chassin, L. (2004) · Annual Review of Psychology · doi:10.1146/annurev.psych.55.090902.142054 · Cited by 352
The Effectiveness of the Nicotine Patch for Smoking Cessation: A Meta-analysis
Fiore, M. C. (1994) · JAMA · doi:10.1001/jama.1994.03510480064036 · Cited by 345
Neurobiology of Addiction: Toward the Development of New Therapies
KOOB, G. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06682.x · Cited by 317
Schoedel, K. A., Hoffmann, E. B., Rao, Y., Sellers, E. M., & Tyndale, R. F. (2004) · Pharmacogenetics · doi:10.1097/00008571-200409000-00006 · Cited by 315
Self-citationPathological gambling: a comprehensive review of biobehavioral findings
Goudriaan, A. E., Oosterlaan, J., de Beurs, E., & Van den Brink, W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.03.001 · Cited by 313
Predicting smoking cessation and major depression in nicotine-dependent smokers
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.7.1122 · Cited by 293 · cited 1×
“Reduced cigarette consumption has been associated with better cessation outcomes in adult”
BackgroundThe health consequences of smoking: Cardiovascular Diseases
McBride, P. E. (1992) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30356-x · Cited by 291
Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.
Nakajima, M., Yamamoto, T., Nunoya, K., Yokoi, T., Nagashima, K., Inoue, K., Funae, Y., Shimada, N., Kamataki, T., & Kuroiwa, Y. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12887-5 · Cited by 284
Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine.
Henningfield, J. E., Miyasato, K., & Jasinski, D. R. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23319-5 · Cited by 282
Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats
Belluzzi, J., Lee, A., Oliff, H., & Leslie, F. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1758-6 · Cited by 280
Nicotine self-administration in animals and humans: similarities and differences
Rose, J. E., & Corrigall, W. A. (1997) · Psychopharmacology · doi:10.1007/s002130050209 · Cited by 261
Nicotine as a modulator of behavior: beyond the inverted U
Picciotto, M. R. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00230-x · Cited by 257
Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats
Adriani, W., Spijker, S., Deroche-Gamonet, V., Laviola, G., Le Moal, M., Smit, A. B., & Piazza, P. V. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04712.2003 · Cited by 257
Nicotine addiction: the possible role of functional upregulation
Buisson, B., & Bertrand, D. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01979-9 · Cited by 254
Nicotine-induced conditioned place preference in adolescent and adult rats
Vastola, B. J., Douglas, L. A., Varlinskaya, E. I., & Spear, L. P. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00818-1 · Cited by 251
Uhl, G. R., Liu, Q.-R., Walther, D., Hess, J., & Naiman, D. (2001) · The American Journal of Human Genetics · doi:10.1086/324467 · Cited by 251
Marubio, L. M., Gardier, A. M., Durier, S., David, D., Klink, R., Arroyo‐Jimenez, M. M., McIntosh, J. M., Rossi, F., Champtiaux, N., Zoli, M., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02564.x · Cited by 242
CYP2A6: a human coumarin 7-hydroxylase
Pelkonen, O., Rautio, A., Raunio, H., & Pasanen, M. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00200-0 · Cited by 236
Jarvis, M. J. (2004) · BMJ · doi:10.1136/bmj.328.7434.277 · Cited by 236
Rao, Y., Hoffmann, E., Zia, M., Bodin, L., Zeman, M., Sellers, E. M., & Tyndale, R. F. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23106-0 · Cited by 231
Self-citationGenetics of alcohol and tobacco use in humans
Tyndale, R. F. (2003) · Annals of Medicine · doi:10.1080/07853890310010014 · Cited by 217
Self-citationNicotine Blood Levels and Subjective Craving for Cigarettes
Jarvik, M. E., Madsen, D. C., Olmstead, R. E., Iwamoto-Schaap, P. N., Elins, J. L., & Benowitz, N. L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00261-6 · Cited by 217
Schizophrenia and Nicotinic Receptors
Freedman, R., Adler, L. E., Bickford, P., Byerley, W., Coon, H., Cullum, M. C., Griffith, J. M., Harris, J. G., Leonard, S., Miller, C., et al. (1994) · Harvard Review of Psychiatry · doi:10.3109/10673229409017136 · Cited by 217
Fujieda, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh258 · Cited by 208
Schilström, B., Svensson, H. M., Svensson, T. H., & Nomikos, G. G. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00114-6 · Cited by 207
Oscarson, M., McLellan, R. A., Gullstén, H., Yue, Q., Lang, M. A., Bernal, M. L., Sinués, B., Hirvonen, A., Raunio, H., Pelkonen, O., et al. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00359-2 · Cited by 203
Why some people smoke and others do not: New perspectives.
Pomerleau, O. F., Collins, A. C., Shiffman, S., & Pomerleau, C. S. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.61.5.723 · Cited by 195
Feng, Y., Niu, T., Xing, H., Xu, X., Chen, C., Peng, S., Wang, L., Laird, N., & Xu, X. (2004) · The American Journal of Human Genetics · doi:10.1086/422194 · Cited by 189
The Genetics of Smoking Initiation and Quantity Smoked in Dutch Adolescent and Young Adult Twins
Koopmans, J. R., Slutske, W. S., Heath, A. C., Neale, M. C., & Boomsma, D. I. (1999) · Behavior Genetics · doi:10.1023/a:1021618719735 · Cited by 182
Oscarson, M., McLellan, R. A., Gullstén, H., Agúndez, J. A. G., Benı́tez, J., Rautio, A., Raunio, H., Pelkonen, O., & Ingelman-Sundberg, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01364-2 · Cited by 181
Laviolette, S. R., & van der Kooy, D. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001197 · Cited by 180
Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking
Sellers, E. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.107651 · Cited by 179
Self-citationPomerleau, O. F. (1995) · Behavior Genetics · doi:10.1007/bf02196925 · Cited by 178
The Genetic Determinants of Smoking
Batra, V., Patkar, A. A., Berrettini, W. H., Weinstein, S. P., & Leone, F. T. (2003) · Chest · doi:10.1378/chest.123.5.1730 · Cited by 175
Wang, H., Tan, W., Hao, B., Miao, X., Zhou, G., He, F., & Lin, D. (2003) · PubMed · Cited by 172
CYP2A6 Gene Deletion Reduces Susceptibility to Lung Cancer
Miyamoto, M., Umetsu, Y., Dosaka‐Akita, H., Sawamura, Y., Yokota, J., Kunitoh, H., Nemoto, N., Sato, K., Ariyoshi, N., & Kamataki, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1089 · Cited by 172
The Genetics of Smoking Persistence in Men and Women: A Multicultural Study
Madden, P. A. F., Heath, A. C., Pedersen, N. L., Kaprio, J. A., Koskenvuo, M. J., & Martin, N. G. (1999) · Behavior Genetics · doi:10.1023/a:1021674804714 · Cited by 166
Nakajima, M. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.112688 · Cited by 165
High Levels of Dopamine Activity in the Basal Ganglia of Cigarette Smokers
Salokangas, R. K. R., Vilkman, H., Ilonen, T., Taiminen, T., Bergman, J., Haaparanta, M., Solin, O., Alanen, A., Syvã«¡hti, E., & Hietala, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.632 · Cited by 164
(2001) · PubMed · Cited by 163
Interindividual variability of coumarin 7-hydroxylation in healthy volunteers
Rautio, A., Kraul, H., Kojo, A., Salmela, E., & Pelkonen, O. (1992) · Pharmacogenetics · doi:10.1097/00008571-199210000-00005 · Cited by 162
An in Vivo Pilot Study Characterizing the New CYP2A6*7, *8, and *10 Alleles
Xu, C. D., Rao, Y. S., Xu, B. Q., Hoffmann, E. B., Jones, J. P., Sellers, E. M., & Tyndale, R. F. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6209 · Cited by 159
Self-citationPitarque, M., von Richter, O., Oke, B., Berkkan, H., Oscarson, M., & Ingelman‐Sundberg, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4990 · Cited by 157
Recollections and repercussions of the first inhaled cigarette
DiFranza, J. R., Savageau, J. A., Fletcher, K. E., Ockene, J. K., Rigotti, N. A., McNeill, A. D., Coleman, M., & Wood, C. D. (2003) · Addictive Behaviors · doi:10.1016/j.addbeh.2003.08.002 · Cited by 155
Nicotine metabolite ratio as a predictor of cigarette consumption
Pomerleau, C., Benowitz, N., Jacob, P., & Pomerleau, O. (2003) · Nicotine & Tobacco Research · doi:10.1080/1462220031000158717 · Cited by 155
Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
Ariyoshi, N., Miyamoto, M., Umetsu, Y., Kunitoh, H., Dosaka‐Akita, H., Sawamura, Y.-I., Yokota, J., Nemoto, N., Sato, K., & Kamataki, T. (2002) · PubMed · Cited by 155
Abreu-Villaça, Y., Seidler, F. J., Qiao, D., Tate, C. A., Cousins, M. M., Thillai, I., & Slotkin, T. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300221 · Cited by 151
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056408 · Cited by 148
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C‐oxidase
Oscarson, M., Gullstén, H., Rautio, A., Bernal, M. L., Sinués, B., Dahl, M., Stengård, J., Pelkonen, O., Raunio, H., & Ingelman‐Sundberg, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01297-6 · Cited by 148
CYP2A6 genetic variation and potential consequences
Xu, C. D., Goodz, S. D., Sellers, E. M., & Tyndale, R. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00065-0 · Cited by 147
Self-citationFlores, C. M., Dávila‐García, M. I., Ulrich‐Lai, Y. M., & Kellar, K. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052216.x · Cited by 142
Genetic variation of CYP2A6, smoking, and risk of cancer
London, S. J., Idle, J. R., Daly, A. K., & Coetzee, G. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04984-8 · Cited by 142
O’Loughlin, J. L., Paradis, G., Kim, W., DiFranza, J. R., Meshefedjian, G. A., McMillan-Davey, E., Wong, S., Hanley, J., & Tyndale, R. F. (2004) · Tobacco Control · doi:10.1136/tc.2003.007070 · Cited by 141
Self-citationMechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs, L. L., Peter, R. M., Thompson, S. J., Rettie, A. E., & Trager, W. F. (1997) · PubMed · Cited by 140
Early experiences with tobacco among women smokers, ex‐smokers, and never‐smokers
Pomerleau, O. F., Pomerleau, C. S., & Brouwer, R. J. N. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.93459515.x · Cited by 139
Yoshida, R. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00090-0 · Cited by 134
Shimada, T., Yamazaki, H., & Guengerich, F. P. (1996) · Xenobiotica · doi:10.3109/00498259609046718 · Cited by 130
Gu, D., Hinks, L. J., Morton, N. E., & Day, I. N. M. (2000) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2000.6450383.x · Cited by 126
Daigo, S., Takahashi, Y., Fujieda, M., Ariyoshi, N., Yamazaki, H., Koizumi, W., Tanabe, S., Saigenji, K., Nagayama, S., Ikeda, K., et al. (2002) · Pharmacogenetics · doi:10.1097/00008571-200206000-00005 · Cited by 125
Law, M., Morris, J. K., Watt, H., & Wald, N. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.287 · Cited by 120
Loriot, M., Rebuissou, S., Oscarson, M., Cénée, S., Miyamoto, M., Ariyoshi, N., Kamataki, T., Hémon, D., Beaune, P. H., & Stücker, I. (2001) · Pharmacogenetics · doi:10.1097/00008571-200102000-00005 · Cited by 120
Nicotine's role in smoking: An analysis of nicotine regulation.
McMorrow, M. J., & Foxx, R. M. (1983) · Psychological Bulletin · doi:10.1037/0033-2909.93.2.302 · Cited by 118
Nakajima, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.103957 · Cited by 118
Elucidating the role of genetic factors in smoking behavior and nicotine dependence
Lerman, C., & Berrettini, W. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10003 · Cited by 114 · cited 3×
“Biologic and psychosocial renforcing effects experienced by individuals likely deermine the progression through these stages.(19) Individals with particular genetic predispositions and those ho are exposed to certain environmental influences ay be at greater risk for dependence on nicotine.”
BackgroundTrans‐3′‐hydroxycotinine: Disposition kinetics, effects and plasma levels during cigarette smoking
Benowitz, N. L., & Jacob, P. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01309.x · Cited by 114
Nunoya, K., Yokoi, T., Kimura, K., Inoue, K., Kodama, T., Funayama, M., Nagashima, K., Funae, Y., Green, C., Kinoshita, M., et al. (1998) · Pharmacogenetics · doi:10.1097/00008571-199806000-00006 · Cited by 111
Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine
Benowitz, N. L., Zevin, S., & Jacob, P. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37887-5 · Cited by 108
Luca, V. D., Wong, A. H. C., Müller, D. J., Wong, G. W. H., Tyndale, R. F., & Kennedy, J. L. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300466 · Cited by 107
Self-citationNicotine renal excretion rate influences nicotine intake during cigarette smoking.
Benowitz, N. L., & Jacob, P. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23322-5 · Cited by 106
Hadidi, H. F., Zahlsen, K., Idle, J. R., & Cholerton, S. (1997) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(97)00066-5 · Cited by 105
Cigarette brand-switching: effects on smoke exposure and smoking behavior.
Zacny, J. P., & Stitzer, M. L. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22128-0 · Cited by 103
A Novel Single Nucleotide Polymorphism Altering Stability and Activity of CYP2A6
Ariyoshi, N., Sawamura, Y.-I., & Kamataki, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4422 · Cited by 103
Oscarson, M., McLellan, R. A., Asp, V., Ledesma, M., Bernal, M. L., Sinués, B., Rautio, A., & Ingelman‐Sundberg, M. (2002) · Human Mutation · doi:10.1002/humu.10126 · Cited by 102
Patten, C. (1997) · Carcinogenesis · doi:10.1093/carcin/18.8.1623 · Cited by 102
A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population
Li, M. D., Ma, J. Z., Cheng, R., Dupont, R. T., Williams, N. J., Crews, K. M., Payne, T. J., & Elston, R. C. (2003) · BMC Genetics · doi:10.1186/1471-2156-4-s1-s103 · Cited by 97
Genetic and Social Determinants of Initiation and Age at Onset of Smoking in Australian Twins
Heath, A. C., Kirk, K. M., Meyer, J. M., & Martin, N. G. (1999) · Behavior Genetics · doi:10.1023/a:1021670703806 · Cited by 97
Polymorphisms in genes involved in neurotransmission in relation to smoking
Arinami, T., Ishiguro, H., & Onaivi, E. S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00816-5 · Cited by 93
Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal
Teneggi, V., Tiffany, S. T., Squassante, L., Milleri, S., Ziviani, L., & Bye, A. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1176-1 · Cited by 92
Applying genetic approaches to the treatment of nicotine dependence
Lerman, C. E., & NIAURA, R. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205801 · Cited by 90
Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics
Sullivan, P. F., Neale, B. M., van den Oord, E. J. C. G., Miles, M. F., Neale, M. C., Bulik, C. M., Joyce, P. R., Straub, R. E., & Kendler, K. S. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20138 · Cited by 89
Decreasing smoking behaviour and risk through CYP2A6 inhibition
Sellers, E. M., Tyndale, R. F., & Fernandes, L. C. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02704-1 · Cited by 83
Self-citationKiyotani, K., Yamazaki, H., Fujieda, M., Iwano, S., Matsumura, K., Satarug, S., Ujjin, P., Shimada, T., Guengerich, F. P., Parkinson, A., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200311000-00005 · Cited by 71
Interindividual variability of coumarin 7-hydroxylation in a Turkish population
İşcan, M., Rostami, H., G�ray, T., Pelkonen, O., & Rautio, A. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00191161 · Cited by 69
Smith, G. B. J., Bend, J. R., Bedard, L. L., Reid, K. R., Petsikas, D., & Massey, T. E. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1134 · Cited by 61
Lueders, K. K., Hu, S., McHugh, L., Myakishev-Rempel, M., Sirota, L. A., & Hamer, D. H. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200110098419 · Cited by 57
Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method
Mwenifumbo, J. C., Myers, M. G., Wall, T. L., Lin, S., Sellers, E. M., & Tyndale, R. F. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200503000-00008 · Cited by 56
Self-citationNicotine withdrawal in the rat: role of α7 nicotinic receptors in the ventral tegmental area
Nomikos, G. G., Hildebrand, B. E., Panagis, G., & Svensson, T. H. (1999) · Neuroreport · doi:10.1097/00001756-199903170-00007 · Cited by 45 · cited 1×
“45 mediate effects of the nicotine withdrawal syndrome”
BackgroundAssociation of CYP2A6 Gene Deletion with Cigarette Smoking Status in Japanese Adults.
Ando, M., Hamajima, N., Ariyoshi, N., Kamataki, T., Matsuo, K., & Ohno, Y. (2003) · Journal of Epidemiology · doi:10.2188/jea.13.176 · Cited by 44
Meanings of smoking and adolescent smoking across ethnicities
Spruijt‐Metz, D., Gallaher, P. E., Unger, J. B., & Johnson, C. A. (2004) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2003.09.009 · Cited by 44
Single-Dose Methoxsalen Effects on Human Cytochrome P-450 2A6 Activity
Kharasch, E. D., Hankins, D. C., & Taraday, J. K. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14998-7 · Cited by 39
An Improved Assay Shows No Association Between the CYP2A6 Gene and Cigarette Smoking Behavior
Sabol, S. Z., & Hamer, D. H. (1999) · Behavior Genetics · doi:10.1023/a:1021642323602 · Cited by 30
Patten, C., Peterson, L. A., & Murphy, S. E. (1998) · PubMed · Cited by 15
Cited by
Benowitz, N. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809890 · Cited by 1,508
Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,166
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics
Benowitz, N. L. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094742 · Cited by 979
“, people with variant CYP2A6 genes associated with substantially reduced enzyme activity) smoke on average fewer cigarettes per day and tend to have higher carbon monoxide levels than do normal metabolizers (37).”
BackgroundGuidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824
“Investigators are referred to informative reviews (Malaiyandi et al. 2005; Miksys and Tyndale 2002) for additional details on cytochrome P450s, nicotine, and smoking.”
BackgroundSelf-citationAlberg, A. J., Ford, J. G., & Samet, J. M. (2007) · Chest · doi:10.1378/chest.07-1347 · Cited by 626
Metadata
- Authors
- Malaiyandi, V., Sellers, E. M., & Tyndale, R. F.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2005-03
- Volume
- 77
- Issue
- 3
- Pages
- 145-158
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2098436801
- Cited by
- 267
- References
- 117
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.